KLCM Advisors’s DexCom DXCM Stock Holding History

KLCM Advisors’s Portfolio DXCM Stock Details DXCM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$407K	Hold	6,037	–	–	0.03%	199
2026 Q1	$379K	Hold	6,037	–	–	0.03%	188
2025 Q4	$401K	Buy	+6,037	New	+$390K	0.03%	170

Other funds holding DXCM

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

UBS AM Chicago, Illinois $550B AUM 43.33% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

KLCM Advisors's DXCM Position: Q2 2026 in Review

KLCM Advisors held its DexCom (DXCM) position steady in Q2 2026 at 6,037 shares worth $407K. The position accounts for 0.03% of the portfolio, ranked #199.

KLCM Advisors first reported a position in DXCM in Q4 2025 and has held it in 3 quarters since. 974 funds tracked by Wall St. Rank hold DXCM as of Q2 2026.

KLCM Advisors held 6,037 shares of DexCom worth $407K as of Q2 2026.
KLCM Advisors left its DexCom share count unchanged in Q2 2026.
DexCom made up 0.03% of KLCM Advisors's portfolio in Q2 2026, its #199 holding.
KLCM Advisors first reported a position in DexCom in Q4 2025 and has held it in 3 quarters since.
974 funds tracked by Wall St. Rank held DexCom as of Q2 2026.

Based on KLCM Advisors's 13F filing for Q2 2026, filed 6 Aug 2026.